Published in AIDS Weekly, August 13th, 2001
Data, presented at the 1st International AIDS Society (IAS) Conference on HIV Pathogenesis and Treatment, showed a greater response in reduction of viral load with a regimen containing Sustiva to less than 50 copies/mL (52%; 78/154) compared with a protease inhibitor-containing regimen (30%; 43/148). The difference was statistically...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.